日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data

利用真实世界数据和NATALEE数据,基于机器学习预测HR+/HER2-早期乳腺癌远处复发风险和瑞博西尼治疗效果

Howard, Frederick M; Fasching, Peter A; Santa-Maria, Cesar A; Lim, Elgene; Sparano, Joseph A; Lustberg, Maryam B; Bachelot, Thomas; Blyuss, Oleg; Brezden-Masley, Christine; Park, Yeon Hee; Akdere, Murat; Ye, Fen; Pantoja, Kristyn; Kurz, Christoph; Dominguez Castro, Patricia; Razavi, Pedram

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03

纳武利尤单抗联合伊匹木单抗对比卡培他滨作为新辅助化疗后残留病灶的三阴性乳腺癌患者术后治疗:一项多中心、随机、开放标签的II期试验 - BREASTIMMUNE-03

Trédan, Olivier; Loirat, Delphine; Chabaud, Sylvie; Toussaint, Philippe; Petit, Thierry; Viret, Frédéric; Levy, Christelle; Robert, Aurélien; Grenier, Julien; Mansi, Laura; Spano, Jean-Philippe; Patsouris, Anne; Derbel, Olfa; Jouannaud, Christelle; Ferrero, Jean Marc; Frenel, Jean Sébastien; Molin, Yann; Doublet, Louis; Heudel, Pierre-Etienne; Pierga, Jean-Yves; Garin, Gwenaële; Pérol, David; Bachelot, Thomas

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer

BRCA1/2、PALB2 突变与 HR+ 转移性乳腺癌一线 CDK4/6 抑制剂疗效

Guinel, Timothé; Lusque, Amélie; Mailliez, Audrey; Massard, Vincent; Jacot, William; Guiu, Severine; de la Motte Rouge, Thibault; Brain, Etienne; Desmoulins, Isabelle; Arnedos, Monica; Bailleux, Caroline; Goncalves, Anthony; Levy, Christelle; Bachelot, Thomas; Bosquet, Lise; Delaloge, Suzette; Frénel, Jean-Sébastien

Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial

Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌:一项II期试验

Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

识别高危雌激素受体阳性/人表皮生长因子受体2阴性早期乳腺癌中复发率低的患者:临床病理检测方法的开发与验证

Bidard, François-Clément; Gessain, Grégoire; Bachelot, Thomas; Frechin, Lucie; Vincent-Salomon, Anne; Drubay, Damien; Lemonnier, Jérôme; Walter, Thomas; Penault-Llorca, Frédérique; Martin, Anne-Laure; Gaudin, Catherine; Bichat, Antoine; Sassi, Farah; Berlemont, Sylvain; Chavez-MacGregor, Mariana; Rugo, Hope S; Badoual, Cécile; Pistilli, Barbara; Ribeiro, Joana; Di Meglio, Antonio; Lacroix-Triki, Magali; Vaz Luis, Ines; Lerousseau, Marvin; André, Fabrice

Erratum: De Novo Oligometastatic Breast Cancer

勘误表:新发寡转移性乳腺癌

Pusztai, Lajos; Rozenblit, Mariya; Dubsky, Peter; Bachelot, Thomas; Kirby, Anna M; Linderholm, Barbro K; White, Julia R; Chmura, Steven J; Carey, Lisa A; Chua, Boon H; Miller, Kathy D

Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature

雌激素受体阳性、HER2阴性、获得性芳香化酶抑制剂耐药晚期乳腺癌的基因组图谱:ESR1改变相关基因特征的鉴定

Barraud, Solenn; Vacher, Sophie; Schiffler, Camille; Wong, Jennifer; Hamza, Abderaouf; Courtois, Laura; Pinton, Antoine; Servant, Nicolas; Baulande, Sylvain; Attignon, Valery; Soubeyran, Isabelle; Rouleau, Etienne; Coussy, Florence; Campone, Mario; Legrand, François; Jimenez, Marta; André, Fabrice; Bachelot, Thomas; Bièche, Ivan

Exceptional responses to Trastuzumab deruxtecan in HER2-positive breast cancer: two illustrative case reports

HER2阳性乳腺癌患者对曲妥珠单抗德鲁替康的卓越疗效:两例病例报告

Ballatore, Zelmira; Vanacker, Helene; Chiari, Rita; Bachelot, Thomas

Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach

利用计算方法发现侵袭性乳腺癌中表观遗传沉默的抑癌基因

Vitte, Anne-Laure; Chuffart, Florent; Jacquet, Emmanuelle; Nika, Eleni; Mousseau, Mireille; Jung, Ina; Tabone-Eglinger, Séverine; Bachelot, Thomas; Rousseaux, Sophie; Khochbin, Saadi; Bourova-Flin, Ekaterina

ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer

ELAINE 3:拉索昔芬联合阿贝西利治疗ER+/HER2-、ESR1突变转移性乳腺癌的3期研究

Goetz, Matthew P; Wander, Seth A; Bachelot, Thomas; de Nonneville, Alexandre; Gal-Yam, Einav Nili; Sammons, Sarah L; Shen, Sherry; Twelves, Chris; Boruta, Gina; Portman, David J; Damodaran, Senthil